Zymeworks (ZYME) FCF Margin (2021 - 2026)
Zymeworks (ZYME) posted FCF Margin of 1902.74% for Q1 2026, down 341.46% sequentially from 431.01% in Q4 2025, and down 189011.0% YoY from N/an in Q1 2025.
Zymeworks (ZYME) FCF Margin (2021 - 2026) Analysis & Trends
Zymeworks has reported FCF Margin for 6 years, with the latest figure at 1902.74% in Q1 2026.
- Quarterly FCF Margin fell 189011.0% year-over-year to 1902.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 94.66% (down 1135.0% YoY) and the FY2025 annual result came in at 32.58%, up 11426.0% from the prior year.
- FCF Margin retreated to 1902.74% in Q1 2026 per ZYME's latest filing, from 431.01% in the prior quarter.
- Over five years, FCF Margin peaked at 100.87% in Q4 2022 and troughed at 3109.08% in Q1 2022.
- A 5-year average of 603.96% and a median of 134.78% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2026: FCF Margin soared 287417 bps in 2023, then sank 189011 bps in 2026.
- Over 5 years, FCF Margin stood at 100.87% in 2022, then slipped by 7 bps to 94.11% in 2023, then plunged by 243 bps to 134.78% in 2024, then sank by 220 bps to 431.01% in 2025, then slumped by 341 bps to 1902.74% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 1902.74%, 431.01%, and 115.24% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Zymeworks | 1.79 Bn | 1.52 Bn | - | -696.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -696.03% |
| Mar 31, 2026 | -1,902.74% |
| Dec 31, 2025 | -431.01% |
| Sep 30, 2025 | -115.24% |
| Jun 30, 2025 | 23.72% |
| Mar 31, 2025 | -12.63% |
| Dec 31, 2024 | -134.78% |
| Sep 30, 2024 | -42.37% |
| Jun 30, 2024 | -133.92% |
| Mar 31, 2024 | -375.62% |
| Dec 31, 2023 | 94.11% |
| Sep 30, 2023 | -264.13% |
| Jun 30, 2023 | -102.84% |
| Mar 31, 2023 | -234.91% |
| Dec 31, 2022 | 100.87% |
| Sep 30, 2022 | -2,570.32% |
| Jun 30, 2022 | -1,056.36% |
| Mar 31, 2022 | -3,109.08% |
| Dec 31, 2021 | -634.91% |